|
161
|
|
|
Tropomyosin 3 pseudogene 2 |
TPM5P, dJ1125A11.2 |
|
|
162
|
|
|
TRNA aspartic acid methyltransferase 1 |
DMNT2, DNMT2, MHSAIIP, PUMET, RNMT1 |
|
|
163
|
|
|
TSC22 domain family member 3 |
DIP, DSIPI, GILZ, TSC-22R |
|
|
164
|
|
|
Torsin family 1 member A |
AMC5, DQ2, DYT1 |
|
|
165
|
|
|
Thymidine phosphorylase |
ECGF, ECGF1, MEDPS1, MNGIE, MTDPS1, PDECGF, TP, hPD-ECGF |
Experimental arthritis, Carcinoma, Colonic neoplasm, Colorectal neoplasm, Esophageal squamous cell carcinoma, Intestinal obstruction, Mitochondrial complex deficiency, Mitochondrial disease, Mitochondrial dna depletion syndrome, Mitochondrial encephalomyopathy, Pancreatic neoplasm, Stomach neoplasms, Urinary bladder cancer, Visceral neuropathy |
|
166
|
|
|
Tetratricopeptide repeat domain 21A |
IFT139A, SPGF37, STI2, Thm2 |
|
|
167
|
|
|
Tet methylcytosine dioxygenase 3 |
BEFAHRS, hCG_40738 |
Attention deficit hyperactivity disorder, Autism, Breast cancer, Kidney disease, Intellectual developmental disorder, Intellectual developmental disorder dysmorphic facial hearing joint, Lung cancer, Neurodevelopmental disorders, Rheumatoid arthritis, Schizophrenia, Squamous cell carcinoma, Substance abuse, Systemic lupus erythematosus |
|
168
|
|
|
Transmembrane protein 17 |
- |
|
|
169
|
|
|
Tripartite motif containing 65 |
4732463G12Rik |
|
|
170
|
|
|
Transmembrane anterior posterior transformation 1 |
CMVFR, OCLSBG |
|